SynthesisFrontiers in medicine2025
Construction of a management and prevention program for targeted therapy-induced hand-foot skin reaction.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To construct a management and prevention program for targeted therapy-induced hand-foot skin reactions (HFSR). Design: A systematic review with meta-analysis. Methods: Based on a literature review and expert consensus meetings, a two-round expert panel discussion involving 10 experts was conducted to finalize the HFSR management and prevention program. Data sources: Articles were systematically searched on the CNKI, Wanfang Database, VIP, PubMed, UpToDate, Embase, and Cochrane Library, and guideline publication websites, NGC, NCCN, NICE, SIGN and ESMO databases from inception up to June 2023. Results: The final program comprised 8 primary indicators, 16 secondary indicators, 36 tertiary indicators, and 54 quaternary entries. These include baseline level and hand-foot skin assessment, skin erythema care, skin keratosis care, skin blister management, skin ulcer care, skin pain management, management of other accompanying symptoms, and hand-foot protection and prevention education. Conclusion: This management and prevention program, constructed based on evidence and expert discussion, is scientifically sound and clinically applicable, providing reliable guidance for the management and prevention of HFSR in clinical practice. Impact: Based on the best available evidence for managing and preventing hand-foot skin reactions induced by targeted therapies, we recommend that nursing leaders implement personalized symptom management plans tailored to the common symptoms of these reactions. Such an approach may help in the early detection of hand-foot skin reactions and alleviate patients' skin pain effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.